Risk of reproductive complications following chlamydia testing: a population-based retrospective cohort study in Denmark

The Lancet Infectious Diseases

Volumn 16, Issue 9, 2016, Pages 1057-1064

  Davies, Bethan ^a   Turner, Katy M E ^b   Frølund, Maria ^c   Ward, Helen ^a   May, Margaret T ^b   Rasmussen, Steen ^d   Benfield, Thomas ^d,e   Westh, Henrik ^d,e  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c STATENS SERUM INSTITUT   (Denmark)

^d HVIDOVRE HOSPITAL   (Denmark)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHLAMYDIASIS; CLINICAL OUTCOME; COHORT ANALYSIS; CONTROLLED STUDY; DENMARK; DIAGNOSTIC TEST; ECTOPIC PREGNANCY; FEMALE; FEMALE INFERTILITY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; PELVIC INFLAMMATORY DISEASE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK; YOUNG ADULT; CHLAMYDIA TRACHOMATIS; COMPLICATION; INCIDENCE; ISOLATION AND PURIFICATION; PREGNANCY;

ADOLESCENT; ADULT; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; DENMARK; FEMALE; HUMANS; INCIDENCE; PELVIC INFLAMMATORY DISEASE; PREGNANCY; PREGNANCY, ECTOPIC; RETROSPECTIVE STUDIES; RISK;

EID: 84999853091     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(16)30092-5     Document Type: Article

References (29)

1. 1 ECDC. Chlamydia control in Europe: literature review, 2014, European Centre for Disease Prevention and Control, Stockholm.
2. 2 Haggerty, CL, Gottlieb, SL, Taylor, BD, Low, N, Xu, F, Ness, RB, Risk of sequelae after Chlamydia trachomatis genital infection in women. J Infect Dis 201:suppl 2 (2010), S134–S155.
3. 3 Risser, WL, Risser, JM, The incidence of pelvic inflammatory disease in untreated women infected with Chlamydia trachomatis: a structured review. Int J STD AIDS 18 (2007), 727–731.
4. 4 Wallace, LA, Scoular, A, Hart, G, Reid, M, Wilson, P, Goldberg, DJ, What is the excess risk of infertility in women after genital chlamydia infection? A systematic review of the evidence. Sex Transm Infect 84 (2008), 171–175.
5. 5 Low, N, Egger, M, Sterne, JAC, et al. Incidence of severe reproductive tract complications associated with diagnosed genital chlamydial infection: the Uppsala Women's Cohort Study. Sex Transm Infect 82 (2006), 212–218.
6. 6 Herzog, SA, Heijne, JC, Althaus, CL, Low, N, Describing the progression from Chlamydia trachomatis and Neisseria gonorrhoeae to pelvic inflammatory disease: systematic review of mathematical modeling studies. Sex Transm Dis 39 (2012), 628–637.
7. 7 Adams, EJ, Turner, KM, Edmunds, WJ, The cost effectiveness of opportunistic chlamydia screening in England. Sex Transm Infect 83 (2007), 267–274 discussion 74–05.
8. 8 Andersen, B, Gundgaard, J, Kretzschmar, M, Olsen, J, Welte, R, Oster-Gaard, L, Prediction of costs, effectiveness, and disease control of a population-based program using home sampling for diagnosis of urogenital Chlamydia trachomatis infections. Sex Transm Dis 33 (2006), 407–415.
9. 9 de Vries, R, van Bergen, JEAM, de Jong-van den Berg, LTW, Postma, MJ, Grp, PCS, Systematic screening for Chlamydia trachomatis: estimating cost-effectiveness using dynamic modeling and Dutch data. Value Health 9 (2006), 1–11.
10. 10 Gillespie, P, O'Neill, C, Adams, E, et al. The cost and cost-effectiveness of opportunistic screening for Chlamydia trachomatis in Ireland. Sex Transm Infect 88 (2012), 222–228.
11. 11 Hu, D, Hook, EW 3rd, Goldie, SJ, The impact of natural history parameters on the cost-effectiveness of Chlamydia trachomatis screening strategies. Sex Transm Dis 33 (2006), 428–436.
12. 12 Welte, R, Kretzschmar, M, Leidl, R, Van den Hoek, A, Jager, JC, Postma, MJ, Cost-effectiveness of screening programs for Chlamydia trachomatis—a population-based dynamic approach. Sex Transm Dis 27 (2000), 518–529.
13. 13 Bakken, IJ, Ghaderi, S, Incidence of pelvic inflammatory disease in a large cohort of women tested for Chlamydia trachomatis: a historical follow-up study. BMC Infect Dis, 9, 2009, 130.
14. 14 Davies, B, Ward, H, Leung, S, et al. Heterogeneity in risk of pelvic inflammatory diseases after chlamydia infection: a population-based study in Manitoba, Canada. J Infect Dis 210:suppl 2 (2014), S549–S555.
15. 15 Bakken, IJ, Skjeldestad, FE, Lydersen, S, Nordbo, SA, Births and ectopic pregnancies in a large cohort of women tested for Chlamydia trachomatis. Sex Transm Dis 34 (2007), 739–743.
16. 16 Andersen, B, Ostergaard, L, Puho, E, Skriver, MV, Schonheyder, HC, Ectopic pregnancies and reproductive capacity after Chlamydia trachomatis positive and negative test results: a historical follow-up study. Sex Transm Dis 32 (2005), 377–381.
17. 17 Price, MJ, Ades, AE, Angelis, DD, et al. Mixture-of-exponentials models to explain heterogeneity in studies of the duration of Chlamydia trachomatis infection. Stat Med 32 (2013), 1547–1560.
18. 18 Simms, I, Warburton, F, Westrom, L, Diagnosis of pelvic inflammatory disease: time for a rethink. Sex Transm Infect 79 (2003), 491–494.
19. 19 Hillis, SD, Nakashima, A, Amsterdam, L, et al. The impact of a comprehensive chlamydia prevention program in Wisconsin. Fam Plann Perspect 27 (1995), 108–111.
20. 20 Ross, JD, Hughes, G, Why is the incidence of pelvic inflammatory disease falling?. BMJ, 348, 2014, g1538.
21. 21 Reekie, J, Donovan, B, Guy, R, et al. Hospitalisations for pelvic inflammatory disease temporally related to a diagnosis of Chlamydia or gonorrhoea: a retrospective cohort study. PLoS One, 9, 2014, e94361.
22. 22 Søborg, BCS, Hoffmann, S, Gonorrhoea 2011. EPI-News number 36. http://www.ssi.dk/English/News/EPI-NEWS/2012/No%2036%20-%202012.aspx, Sept 5, 2012 (accessed Feb 24, 2015).
23. 23 Bohm, MK, Newman, L, Satterwhite, CL, Tao, G, Weinstock, HS, Pelvic inflammatory disease among privately insured women, United States, 2001–2005. Sex Transm Dis 37 (2010), 131–136.
24. 24 Ratelle, S, Yokoe, D, Blejan, C, et al. Predictive value of clinical diagnostic codes for the CDC case definition of pelvic inflammatory disease (PID): implications for surveillance. Sex Transm Dis 30 (2003), 866–870.
25. 25 Satterwhite, CL, Yu, O, Raebel, MA, et al. Detection of pelvic inflammatory disease: development of an automated case-finding algorithm using administrative data. Infect Dis Obstet Gynecol, 2011, 2011, 428351.
26. 26 Geisler, WM, Wang, C, Morrison, SG, Black, CM, Bandea, CI, Hook, EW, The natural history of untreated Chlamydia trachomatis infection in the interval between screening and returning for treatment. Sex Transm Dis 35 (2008), 119–123.
27. 27 Davies, B, The association between Chlamydia trachomatis and pelvic inflammatory disease: findings from observational studies, 2014, Imperial College London, London.
28. 28 Hillis, SD, Owens, LM, Marchbanks, PA, Amsterdam, LF, Mac Kenzie, WR, Recurrent chlamydial infections increase the risks of hospitalization for ectopic pregnancy and pelvic inflammatory disease. Am J Obstet Gynecol 176 (1997), 103–107.
29. 29 Hadgu, A, Sternberg, M, Reproducibility and specificity concerns associated with nucleic acid amplification tests for detecting Chlamydia trachomatis. Eur J Clin Microbiol Infect Dis 28 (2009), 9–15.